Clinical Services
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
269
NCT05642780
SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors
Phase: Phase 2
Role: Collaborator
Start: Jan 17, 2023
Completion: Dec 31, 2027
NCT05841160
Thorough QT/QTc Study to Evaluate the Effects of Ecopipam (EBS-101) on Cardiac Repolarization
Phase: Phase 1
Start: Mar 15, 2023
Completion: May 12, 2023
Loading map...